You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Response to anti- CTLA-4 and anti PD1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Profiling of Circulating Immune Cells to Uncover Response

Not yet recruiting
  • Melanoma
    • (no location specified)
    Nov 23, 2023

    Hepatocellular Carcinoma Trial in Beijing (AK104, Lenvatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Oct 17, 2022

    SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)

    Not yet recruiting
    • SCLC,Extensive Stage
    • AK104 IV infusionï¼›Chiauranib oral
    • Changchun, Jilin, China
      Jilin Province Cancer Hospital
    Aug 16, 2022

    Hepatocellular Carcinoma Trial in Hangzhou (AK104 lenvatinib, AK104)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • AK104 lenvatinib
    • AK104
    • Hangzhou, Zhejiang, China
      The first affilited hospital zhejiang university school of medci
    Oct 17, 2022

    Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

    Recruiting
    • Melanoma (Skin)
    • +4 more
    • Bloomington, Minnesota
    • +7 more
    Jan 31, 2023

    Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

    Recruiting
    • Leptomeningeal Metastasis
    • +2 more
    • intrathecal nivolumab and intrathecal ipilimumab
    • Geneva, Switzerland
    • +2 more
    Dec 18, 2022

    NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

    Terminated
    Has Results
    • Non-small Cell Lung Cancer
    • Saint Petersburg, Florida
    • +2 more
    Oct 22, 2022

    Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Trial (SBRT, Cadonilimab)

    Not yet recruiting
    • Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Feb 8, 2023

    Head Neck Cancer Trial in Boston (Oral Decitabine, Durvalumab)

    Active, not recruiting
    • Head and Neck Cancer
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 30, 2022

    NPC Trial in Guangzhou (Sintilimab, IBI310)

    Active, not recruiting
    • NPC
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 3, 2022

    Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

    Not yet recruiting
    • Metastatic Melanoma
    • Advanced Melanoma
    • San Francisco, California
      University of California, San Francisco
    Jan 13, 2023

    Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

    Recruiting
    • Advanced Cancer
    • +7 more
    • Scottsdale, Arizona
    • +14 more
    Sep 15, 2022

    Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 31, 2022

    Recurrent or Metastatic Cervical Cancer Trial in Changsha, Hangzhou (AK104, Bevacizumab, Paclitaxel)

    Active, not recruiting
    • Recurrent or Metastatic Cervical Cancer
    • AK104
    • +3 more
    • Changsha, Hunan, China
    • +1 more
    Mar 28, 2022

    Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

    Not yet recruiting
    • Cervical Cancer
    • Anti-PD-1 antibody balstilimab
    • Amsterdam, Netherlands
      Amsterdam UMC
    Oct 17, 2023

    Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Davis, California
    • +2 more
    Jan 5, 2023

    Skin Health and Quality of Life in Patients Receiving

    Not yet recruiting
    • Lung Cancer
    • +7 more
    • EQ-5D-5L questionnaire
    • +2 more
    • Roma, Italy
      Roberto Iacovelli
    May 17, 2023

    BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)

    Terminated
    • BRAF V600E Mutation Present
    • +7 more
    • Boston, Massachusetts
    • +1 more
    Mar 9, 2022

    Colorectal Cancer Stage IV, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial (Cadonilimab)

    Not yet recruiting
    • Colorectal Cancer Stage IV
    • +2 more
    • (no location specified)
    Jun 19, 2022

    Esophageal Squamous Cell Carcinoma Trial (QL1706)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Aug 4, 2022

    NSCLC (Non-small-cell Lung Cancer) Trial in Changchun (Sintilimab, IBI310)

    Recruiting
    • NSCLC (Non-small-cell Lung Cancer)
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Sep 21, 2022

    Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland

    Not yet recruiting
    • Locally Advanced Thyroid Gland Anaplastic Carcinoma
    • +2 more
    • Chicago, Illinois
    • +1 more
    Jul 7, 2022

    Pre-transplant ICI Exposure and Post-transplant Graft Rejection

    Recruiting
    • Graft Rejection
    • +3 more
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
    Jun 21, 2023

    Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

    Not yet recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Feb 8, 2023